Titan Medical Inc. (TMD.TO)
CAD 1.13
(2150.0%)
CAD 1.13
(2150.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.68 Million | -27.57 Million | -36.61 Million | -845.11 Thousand | -45.96 Million | -41.39 Million |
| Net Income | 6.95 Million | -42.54 Million | -14.85 Million | -24.18 Million | -41.9 Million | -22.63 Million |
| Depreciation & Amortization | 186 Thousand | 859 Thousand | 699 Thousand | 236.84 Thousand | 32.55 Thousand | 29.04 Thousand |
| Deferred income taxes | 165 Thousand | -56 Thousand | 56 Thousand | 27.99 Million | -19.78 Million | 6.73 Million |
| Stock-based compensation | 996 Thousand | 4.08 Million | 4.03 Million | 1.09 Million | 1.65 Million | 1.5 Million |
| Change in working capital | -3.68 Million | 12.19 Million | -10.53 Million | -4.91 Million | 13.3 Million | -2.27 Million |
| Other non-cash items | 65 Thousand | -2.11 Million | -16.01 Million | -1.07 Million | 744.5 Thousand | -24.75 Million |
| Investing Cash Flow | 24 Thousand | -1.02 Million | -755 Thousand | -599.36 Thousand | -458.03 Thousand | -420.58 Thousand |
| Investments in PPE | -213 Thousand | -1.02 Million | -755 Thousand | -599.36 Thousand | -458.03 Thousand | -420.58 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 237 Thousand | -317 Thousand | -385 Thousand | -319 Thousand | -458 Thousand | -420.58 Thousand |
| Financing Cash Flow | -451 Thousand | -419 Thousand | 44.2 Million | 26.09 Million | 35.76 Million | 27.15 Million |
| Debt repayment | -451 Thousand | -421 Thousand | -276 Thousand | -90.05 Thousand | -5100.00 | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 34.17 Million | 24.68 Million | 35.76 Million | 27.15 Million |
| Other Financing Activities | - | 2000.00 | 10.3 Million | 1.5 Million | 35.76 Million | 27.15 Million |
| Accounts receivables | -101 Thousand | 8.27 Million | -10.02 Million | -544.42 Thousand | 8.33 Million | -6.5 Million |
| Accounts payables | -3.18 Million | 1.37 Million | - | - | - | - |
| Inventory | - | -1.37 Million | - | - | - | - |
| Other working capital | -498 Thousand | 3.91 Million | -509 Thousand | -4.37 Million | 4.96 Million | 4.22 Million |
| Cash at beginning of period | 3.28 Million | 32.3 Million | 25.46 Million | 814.49 Thousand | 11.47 Million | 26.13 Million |
| Cash at end of period | 7.54 Million | 3.28 Million | 32.3 Million | 25.46 Million | 814.49 Thousand | 11.47 Million |
| Capital Expenditure | -213 Thousand | -1.02 Million | -755 Thousand | -599.36 Thousand | -458.03 Thousand | -420.58 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | 2.81 Million |
| Net cash flow / Change in cash | 4.25 Million | -29.01 Million | 6.83 Million | 24.65 Million | -10.65 Million | -14.65 Million |
| Free Cash Flow | 4.46 Million | -28.59 Million | -37.37 Million | -1.44 Million | -46.41 Million | -41.81 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.06 Million | -807 Thousand | -3.24 Million | 6.95 Million | 68 Thousand | 12.69 Million |
| Depreciation & Amortization | - | - | 87 Thousand | 186 Thousand | 33 Thousand | 32 Thousand |
| Deferred income taxes | - | - | 1.85 Million | 165 Thousand | -1.41 Million | -26 Thousand |
| Stock-based compensation | 6000.00 | -190 Thousand | -26 Thousand | 996 Thousand | 224 Thousand | 622 Thousand |
| Change in working capital | -628 Thousand | -728 Thousand | 750 Thousand | -3.68 Million | -1.41 Million | -3.7 Million |
| Other non-cash items | 24 Thousand | 35 Thousand | -67 Thousand | 65 Thousand | 733 Thousand | -648 Thousand |
| Investing Cash Flow | - | - | -561 Thousand | 24 Thousand | 182 Thousand | 459 Thousand |
| Investments in PPE | - | - | -61 Thousand | -213 Thousand | -55 Thousand | -41 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -500 Thousand | 237 Thousand | 237 Thousand | 500 Thousand |
| Financing Cash Flow | -146 Thousand | -146 Thousand | -146 Thousand | -451 Thousand | -142 Thousand | -84 Thousand |
| Debt repayment | -146 Thousand | -146 Thousand | -146 Thousand | -451 Thousand | -142 Thousand | -84 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | -142 Thousand | -84 Thousand |
| Accounts receivables | 16 Thousand | - | 456 Thousand | - | -456 Thousand | - |
| Accounts payables | - | - | - | -3.18 Million | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 287 Thousand | 316 Thousand | 294 Thousand | -498 Thousand | -956 Thousand | -3.7 Million |
| Cash at beginning of period | 5.7 Million | 7.54 Million | 8.89 Million | 3.28 Million | 10.62 Million | 1.26 Million |
| Cash at end of period | 3.89 Million | 5.7 Million | 7.54 Million | 7.54 Million | 8.89 Million | 10.62 Million |
| Capital Expenditure | - | - | -61 Thousand | -213 Thousand | -55 Thousand | -41 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.8 Million | -1.83 Million | -1.35 Million | 4.25 Million | -1.72 Million | 9.35 Million |
| Free Cash Flow | -1.66 Million | -1.69 Million | -706 Thousand | 4.46 Million | -1.82 Million | 8.93 Million |
CHSCN
GCB
PSPPROJECT
2217
0331
STEM